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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S279Conclusions: Our data showed that OA defects, created by ACTL in a rabbit
model, were repaired with a new tissue after implantation of ADSC. The
morphological, histological immunohistochemical and Micro-CT data
conﬁrm in general the formation of cartilagewith some hyaline-like features
in the joints treated with the two different ADSC concentrations and partic-
ularly in the group treated with the low ADSC concentration particularly at
short time follow-up. Cell treatments seem to up-regulate the production of
collagen type II anddown-regulate thatof collagenType I,MMP-1andMMP-3
enzymes which are involved in catabolic processes. This work belongs to
a collaborative European Projectwithin the Seventh FrameWork Programme
“Adipose derived stromal cells for osteoarthritis treatment”.
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A LIVING HYALINE CARTILAGINOUS GRAFT FOR CARTILAGE TISSUE
ENGINEERING
K. Su, T. Lau, D.-A. Wang. Nanyang Technological Univ., Singapore, Singapore
Purpose: The objective of this study is to develop and apply an innovative,
tissue engineered, living hyaline cartilaginous graft (LhCG) that is free of
synthetic material components and composed of phenotypically bona ﬁde
hyaline cartilaginous neo-tissues. During the process of neo-tissue
formation in LhCG, an interim biomaterial based novel scaffolding system
plays an intermediate role before a complete removal prior to trans-
plantation. The social-economic importance of this work lies in contribu-
tion of a man-made living and qualiﬁed cartilaginous graft to make up for
the limited regenerations in this musculoskeletal tissue so that it may
substantially serve as a possible solution to the ailments faced by current
ageing population - particularly for regenerative treatment of osteoar-
thritis and other joint related disorders or lesions.
Methods: Technically, two steps of processes are performed for the prep-
aration of LhCG (as reported before). 1) Phase transfer cell culture (PTCC) in
hydrogel scaffold: microspherical pores are created in chondrocytes-
encapsulating alginate gel bulk via a controlled clearance of co-encapsu-
lated gelatin microspheres. By proliferative expansion, the encapsulated
chondrocytic isogenic groups adjacent to the gel/pore interface grow out of
gel phase and ﬁll up the pores, where neo-chondral nodules are formed.
And, 2) LhCG formation by hydrogel removal: expansion and fusion of PTCC
induced neo-tissue nodules within hydrogel bulk constructs macroscopic
3D network of a LhCG that interpenetrates the alginate scaffolds (gel) and
maintains structural integrity during the removal of alginate components
by a dissolving treatment with sodium citrate buffer.
Results: Successful fabrication of LhCG provides a scaffold-free porous
construct made of pure living cartilaginous tissues to act as a graft for
implantation. The results indicate that, by mediation within non-cell-
adhesive hydrogel scaffolds, the delivered chondrocytic phenotype is well
preserved from the very beginning to the end. This performance is
approved both in vitro and in vivo. In situ implantation in animal (rabbit
knee joint) models has demonstrated high success rates in both cartilage
repair and graft-host integration.
Conclusion: The results suggest that LhCG is a promising cartilaginous
graft for cartilage repair. Additionally, with a living tissue based nature,
LhCG may also play a role as a niche for multi-tissue regenerations as well
as an implantable transgenic platform for controlled release in situ.
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IN VITRO CARTILAGE TISSUE ENGINEERING WITH DIFFERENT TYPES OF
COLLAGEN POROUS SCAFFOLDS AND HUMAN BONE MARROW
MESENCHYMAL STEM CELLS
S. Díaz-Prado 1,2, E. Muiños-López 1, T. Hermida-Gómez 1, I. Fuentes-
Boquete 1,2, J. Buján 3, F. De Toro 1,2, F.J. Blanco 1. 1 INIBIC-CHUAC, A
Coruña, Spain; 2 INIBIC- Univ. of A Coruña, A Coruña, Spain; 3Dept. of Med.
Specialties. Univ. of Alcalá de Henares, Madrid, Spain
Purpose: To study the chondrogenic potential of human bone marrow
mesenchymal stem cells (hBM-MSCs) grown on different collagen scaf-
folds and to investigate the utility of these scaffolds to construct cartilage-
like tissue in vitro.
Methods: hBM-MSCs were isolated from human BM stroma and were
expanded in monolayer cultures. hBM-MSCs were characterized by ﬂowcytometryusing hematopoietic andMSCmarkers. At the 3-4th passage, hBM-
MSCs were cultured on different collagen supports. We tested four different
scaffolds: Col I+Col II+heparan sulfate; Col I+Col II+chondroitinsulfate; Col
I+heparin and Col I+chondroitinsulfate. The cell density over the supportwas
300.000cells/cm2. The studyperiodwas30days.hBM-MSCswere cultured in
chondrogenic differentiation medium (Lonza, Group Ltd, Switzerland).
Chondrogenic differentiation was conﬁrmed by histochemical and immu-
nohistochemical analysis. Transmission and scanning electronic microscopy
were performed to study the cell interior and cell morphology.
Results: hBM-MSCs were able to grow not only in the surface but also inside
thedifferent typesof collagen supports. Thepercentageof cells, regarding the
area of the analyzed support,washigher than75% in the Col I+Col II+ heparan
sulfate (Fig. 1A) and higher than 60% in the other scaffolds tested. Moreover,
good cell morphology and cell viability were observed in all the scaffolds
studied. hBM-MSCs showed the formation of cell aggregates with chon-
drocyte-like morphology and produced an extracellular matrix around cells.
At the sametimethathBM-MSCsproliferatedover thesupport theywereable
to degrade the scaffold. Moreover, cellular anchors were observed on the
support (Fig. 1B). hBM-MSCs grown in chondrogenic medium were able to
differentiate into cells that showedcharacteristics similar to chondrocytes. To
demonstrate the chondrogenic differentiation some immunostainings were
performed in order to detect the presence of different characteristic
components of the articular cartilage. As it is shown in ﬁgure 1C and D, the
cells showedpositive immunostaining for type II collagenandoneof themost
abundant proteoglycanof cartilage (aggrecan). Scanningelectronmicroscopy
(Fig.1E) allowedus to study the structure and the porosity of the support and
to observe, with high magniﬁcation, cellular adhesion and morphology.
Transmission electron microscopy (Fig. 1F) showed that cells had large
number of lipid vacuoles and the accumulation of glycogen. Moreover, they
wereembedded inthescaffoldsand theyshowedmanyextensions for secrete
adhesion molecules useful to adhere to the support. In general, there were
cells with large cytoplasm and with a high secretory activity.
Conclusions: Our data demonstrated that these different collagen scaf-
folds were optimal for hBM-MSCs growth. Furthermore, hBM-MSCs
cultured in chondrogenic medium over these scaffolds were able to
differentiate into chondrocyte-like cells and to synthesize extracellular
matrix. These supports are suitable candidates as an alternative cell-carrier
for cartilage tissue engineering since chondrogenic hBM-MSCs and
collagen scaffolds may be used to construct cartilage-like tissue in vitro.
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